Clinical Trial Supply in China: Comply with regulations and benchmark industry practices
The only event focusing on clinical trial supply chain management in China
Compared with Western countries, the growing clinical trials industry in China has many advantages – particularly relating to lower costs - which are why so many multinational pharmaceutical and biotech companies are transferring their clinical trial centres to China.
However, the immature clinical trial supply chain and complicated, changing regulations are still major obstacles for pharmaceutical and biotech companies in the Chinese market
The 4th Annual Clinical Trial Supply Chain China will provide up-to-date regulatory guidelines and industry standards, share successful case studies and explore practical solutions on overcoming challenges in clinical trial supply chain operations in China.
Clinical Trial Supply China 2013 will feature:
4 awards to recognise excellence in the bio/pharma supply chain industry
200+ Chinese Bio/Pharma cold chain & clinical trial supply chain industry stakeholders
90% decision makers and key influencers with responsibilities over the Chinese market
40+ cold chain/clinical trial supply chain expert speakers
20+ exclusive case studies on bio/pharma & clinical trial supply chain management best practices in China
10+ hours of networking plus a dedicated speed networking session with clinical trial supply chain and cold chain professionals and regulators in China
5+ China plenary regulatory updates, presentations & panel discussions
Download the Agenda to learn more about the Summit and the full Speaker line up